Dome Life has completed a full upgrade of its new-generation cell cryopreservation system. Through dual optimization of gradient cooling programs and cryoprotectant formulation, the post-thaw viability of samples has been raised to an industry-leading level.
The upgraded system covers stem cells, immune cells and germ cells, supported by full-process digital traceability: the temperature curve and operation records of every sample can be queried in real time.
The company also announced an expansion of its cell bank capacity to meet the fast-growing demand of cell therapy and research.
